Compare $DXCM vs $EW | Chartloom

Compare

$DXCM vs $EW

Dexcom Inc · Edwards Lifesciences Corp

DXCM

Dexcom Inc

Edwards Lifesciences Corp

Compare $DXCM vs $EW

Comparing Dexcom Inc and Edwards Lifesciences Corp

DXCMDexcom Inc

EWEdwards Lifesciences Corp

DXCMDexcom Inc

Market cap

$32.46B

P/E (TTM)

32.82x

Forward P/E (NTM)

29.31x

Forward P/S (NTM)

5.79x

Rev growth (TTM)

15.5%

YTD performance

26.4%

52W performance

24.1%

FCF yield

4.3%

EWEdwards Lifesciences Corp

Market cap

$49.06B

P/E (TTM)

48.98x

Forward P/E (NTM)

26.35x

Forward P/S (NTM)

6.75x

Rev growth (TTM)

14.6%

YTD performance

-0.1%

52W performance

12.5%

FCF yield

2.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DXCM

Detailed metrics comparison

DXCM

Dexcom Inc

Edwards Lifesciences Corp

Market Cap

DXCM$32.46B

EW$49.06B

Enterprise Value

DXCM$32.65B

EW$46.76B

Price

DXCM$84.11

EW$85.21

P/E Ratio

DXCM32.82x

EW48.98x

P/S Ratio

DXCM6.53x

EW7.53x

EV/Sales

DXCM6.57x

EW7.18x

EV/EBITDA

DXCM21.12x

EW22.50x

P/B Ratio

DXCM12.29x

EW4.62x

P/FCF Ratio

DXCM23.10x

EW34.22x

EV/FCF

DXCM23.24x

EW32.61x

PEG Ratio

DXCM1.54x

EW3.36x

Forward P/E (NTM)

DXCM29.31x

EW26.35x

Forward P/S (NTM)

DXCM5.79x

EW6.75x

Revenue (TTM)

DXCM$4.97B

EW$6.51B

Revenue Growth (YoY)

DXCM15.5%

EW14.6%

Forward Rev Growth

DXCM10.8%

EW9.5%

Gross Margin (TTM)

DXCM64.3%

EW77.8%

Operating Margin (TTM)

DXCM22.9%

EW18.2%

EBITDA Margin (TTM)

DXCM30.1%

EW30.8%

Net Margin (TTM)

DXCM20.1%

EW15.4%

FCF Margin (TTM)

DXCM28.3%

EW22.0%

Net Income (TTM)

DXCM$1,000M

EW$1.00B

FCF (TTM)

DXCM$1.41B

EW$1.43B

EPS (TTM)

DXCM$2.56

EW$1.74

ROE (TTM)

DXCM36.2%

EW9.7%

ROA (TTM)

DXCM14.8%

EW7.4%

ROIC (TTM)

DXCM22.9%

EW9.2%

Cash

DXCM$1.11B

EW$2.91B

Debt

DXCM$1.30B

EW$599M

Net Cash/Debt

DXCM$-190M

EW$2.31B

Current Ratio (TTM)

DXCM1.73x

EW4.52x

Quick Ratio (TTM)

DXCM1.40x

EW3.69x

Debt/Equity (TTM)

DXCM0.49x

EW0.06x

Debt/Assets (TTM)

DXCM0.0%

EW0.0%

Interest Coverage (TTM)

DXCMN/A

EWN/A

Net Debt/EBITDA (TTM)

DXCM0.00x

EW0.00x

Beta

DXCM1.44

EW0.84

52W Performance

DXCM24.1%

EW12.5%

YTD Performance

DXCM26.4%

EW-0.1%

% from 52W High

DXCM-9.2%

EW-11.5%

% from 52W Low

DXCM55.4%

EW17.9%

Asset Turnover (TTM)

DXCM0.74x

EW0.48x

FCF Yield (TTM)

DXCM4.3%

EW2.9%

Earnings Yield (TTM)

DXCM3.1%

EW2.0%

Dividend Yield (TTM)

DXCMN/A

EWN/A

Rule of 40

DXCM43.8

EW36.6

EV/GP/RG

DXCM0.77

EW0.76

Ticker research

View DXCM research View EW research

Metric	DXCM Dexcom Inc	EW Edwards Lifesciences Corp
Market & Valuation
Market Cap	$32.46B	$49.06B
Enterprise Value	$32.65B	$46.76B
Price	$84.11	$85.21
P/E Ratio	32.82x	48.98x
P/S Ratio	6.53x	7.53x
EV/Sales	6.57x	7.18x
EV/EBITDA	21.12x	22.50x
P/B Ratio	12.29x	4.62x
P/FCF Ratio	23.10x	34.22x
EV/FCF	23.24x	32.61x
PEG Ratio	1.54x	3.36x
Forward P/E (NTM)	29.31x	26.35x
Forward P/S (NTM)	5.79x	6.75x
Revenue & Growth
Revenue (TTM)	$4.97B	$6.51B
Revenue Growth (YoY)	15.5%	14.6%
Forward Rev Growth	10.8%	9.5%
Profitability
Gross Margin (TTM)	64.3%	77.8%
Operating Margin (TTM)	22.9%	18.2%
EBITDA Margin (TTM)	30.1%	30.8%
Net Margin (TTM)	20.1%	15.4%
FCF Margin (TTM)	28.3%	22.0%
Net Income (TTM)	$1,000M	$1.00B
FCF (TTM)	$1.41B	$1.43B
EPS (TTM)	$2.56	$1.74
ROE (TTM)	36.2%	9.7%
ROA (TTM)	14.8%	7.4%
ROIC (TTM)	22.9%	9.2%
Financial Health
Cash	$1.11B	$2.91B
Debt	$1.30B	$599M
Net Cash/Debt	$-190M	$2.31B
Current Ratio (TTM)	1.73x	4.52x
Quick Ratio (TTM)	1.40x	3.69x
Debt/Equity (TTM)	0.49x	0.06x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.44	0.84
52W Performance	24.1%	12.5%
YTD Performance	26.4%	-0.1%
% from 52W High	-9.2%	-11.5%
% from 52W Low	55.4%	17.9%
Efficiency & Yields
Asset Turnover (TTM)	0.74x	0.48x
FCF Yield (TTM)	4.3%	2.9%
Earnings Yield (TTM)	3.1%	2.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	43.8	36.6
EV/GP/RG	0.77	0.76
Ticker research	View DXCM research	View EW research

Valuation

P/E Ratio

DXCM

32.82x

48.98x

P/S Ratio

DXCM

6.53x

7.53x

EV/FCF

DXCM

23.24x

32.61x

Growth & revenue

Revenue Growth TTM

DXCM

15.5%

14.6%

Forward Revenue Growth

DXCM

10.8%

9.5%

Profitability & performance

Gross Margin

77.8%

DXCM

64.3%

ROE

DXCM

36.2%

9.7%

FCF Yield %

DXCM

4.3%

2.9%

52-Week Performance

DXCM

24.1%

12.5%

Detailed metrics comparison

DXCM

Dexcom Inc

Edwards Lifesciences Corp

Market Cap

DXCM$32.46B

EW$49.06B

Enterprise Value

DXCM$32.65B

EW$46.76B

Price

DXCM$84.11

EW$85.21

P/E Ratio

DXCM32.82x

EW48.98x

P/S Ratio

DXCM6.53x

EW7.53x

EV/Sales

DXCM6.57x

EW7.18x

EV/EBITDA

DXCM21.12x

EW22.50x

P/B Ratio

DXCM12.29x

EW4.62x

P/FCF Ratio

DXCM23.10x

EW34.22x

EV/FCF

DXCM23.24x

EW32.61x

PEG Ratio

DXCM1.54x

EW3.36x

Forward P/E (NTM)

DXCM29.31x

EW26.35x

Forward P/S (NTM)

DXCM5.79x

EW6.75x

Revenue (TTM)

DXCM$4.97B

EW$6.51B

Revenue Growth (YoY)

DXCM15.5%

EW14.6%

Forward Rev Growth

DXCM10.8%

EW9.5%

Gross Margin (TTM)

DXCM64.3%

EW77.8%

Operating Margin (TTM)

DXCM22.9%

EW18.2%

EBITDA Margin (TTM)

DXCM30.1%

EW30.8%

Net Margin (TTM)

DXCM20.1%

EW15.4%

FCF Margin (TTM)

DXCM28.3%

EW22.0%

Net Income (TTM)

DXCM$1,000M

EW$1.00B

FCF (TTM)

DXCM$1.41B

EW$1.43B

EPS (TTM)

DXCM$2.56

EW$1.74

ROE (TTM)

DXCM36.2%

EW9.7%

ROA (TTM)

DXCM14.8%

EW7.4%

ROIC (TTM)

DXCM22.9%

EW9.2%

Cash

DXCM$1.11B

EW$2.91B

Debt

DXCM$1.30B

EW$599M

Net Cash/Debt

DXCM$-190M

EW$2.31B

Current Ratio (TTM)

DXCM1.73x

EW4.52x

Quick Ratio (TTM)

DXCM1.40x

EW3.69x

Debt/Equity (TTM)

DXCM0.49x

EW0.06x

Debt/Assets (TTM)

DXCM0.0%

EW0.0%

Interest Coverage (TTM)

DXCMN/A

EWN/A

Net Debt/EBITDA (TTM)

DXCM0.00x

EW0.00x

Beta

DXCM1.44

EW0.84

52W Performance

DXCM24.1%

EW12.5%

YTD Performance

DXCM26.4%

EW-0.1%

% from 52W High

DXCM-9.2%

EW-11.5%

% from 52W Low

DXCM55.4%

EW17.9%

Asset Turnover (TTM)

DXCM0.74x

EW0.48x

FCF Yield (TTM)

DXCM4.3%

EW2.9%

Earnings Yield (TTM)

DXCM3.1%

EW2.0%

Dividend Yield (TTM)

DXCMN/A

EWN/A

Rule of 40

DXCM43.8

EW36.6

EV/GP/RG

DXCM0.77

EW0.76

Ticker research

View DXCM research View EW research

Metric	DXCM Dexcom Inc	EW Edwards Lifesciences Corp
Market & Valuation
Market Cap	$32.46B	$49.06B
Enterprise Value	$32.65B	$46.76B
Price	$84.11	$85.21
P/E Ratio	32.82x	48.98x
P/S Ratio	6.53x	7.53x
EV/Sales	6.57x	7.18x
EV/EBITDA	21.12x	22.50x
P/B Ratio	12.29x	4.62x
P/FCF Ratio	23.10x	34.22x
EV/FCF	23.24x	32.61x
PEG Ratio	1.54x	3.36x
Forward P/E (NTM)	29.31x	26.35x
Forward P/S (NTM)	5.79x	6.75x
Revenue & Growth
Revenue (TTM)	$4.97B	$6.51B
Revenue Growth (YoY)	15.5%	14.6%
Forward Rev Growth	10.8%	9.5%
Profitability
Gross Margin (TTM)	64.3%	77.8%
Operating Margin (TTM)	22.9%	18.2%
EBITDA Margin (TTM)	30.1%	30.8%
Net Margin (TTM)	20.1%	15.4%
FCF Margin (TTM)	28.3%	22.0%
Net Income (TTM)	$1,000M	$1.00B
FCF (TTM)	$1.41B	$1.43B
EPS (TTM)	$2.56	$1.74
ROE (TTM)	36.2%	9.7%
ROA (TTM)	14.8%	7.4%
ROIC (TTM)	22.9%	9.2%
Financial Health
Cash	$1.11B	$2.91B
Debt	$1.30B	$599M
Net Cash/Debt	$-190M	$2.31B
Current Ratio (TTM)	1.73x	4.52x
Quick Ratio (TTM)	1.40x	3.69x
Debt/Equity (TTM)	0.49x	0.06x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.44	0.84
52W Performance	24.1%	12.5%
YTD Performance	26.4%	-0.1%
% from 52W High	-9.2%	-11.5%
% from 52W Low	55.4%	17.9%
Efficiency & Yields
Asset Turnover (TTM)	0.74x	0.48x
FCF Yield (TTM)	4.3%	2.9%
Earnings Yield (TTM)	3.1%	2.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	43.8	36.6
EV/GP/RG	0.77	0.76
Ticker research	View DXCM research	View EW research